A small Australian digital health software provider

Global Health Limited (ASX:GLH) develops software for Australian healthcare providers, and the central point for readers is that a Business with roughly $8 to $9 million of annual Revenue has narrowed its reported losses but has not yet reported a profit. The company was founded in 1985, is headquartered in Melbourne and has about 33 employees. Its products are described as a software-as-a-service platform covering electronic medical records, patient administration, practice management and secure messaging, alongside a digital front door patient engagement platform and a consumer personal health record app. Brands listed include MasterCare, PrimaryClinic, HotHealth, ReferralNet and Lifecard.

Latest disclosures

On 27 August 2026 the company lodged its 2026 Appendix 4E and full-year statutory accounts, a FY2026 results summary, a corporate governance statement and an Appendix 4G. The Appendix 4E is the primary source for FY2026 revenue, profit or loss, cash and any auditor comments.

Earlier in 2026 the company lodged a half-year report on 25 February, an investor update on 25 March, and quarterly Appendix 4C Cash Flow reports on 19 January, 22 April and 23 July. The half-year report showed a consolidated loss of $629,201 for the six months to December 2025. Notices of cessation of securities were lodged on 3 and 15 July 2026; such notices typically relate to unquoted securities such as Options or rights lapsing.

Financial history

Revenue was $7.82 million, $8.66 million and $8.67 million for FY2023, FY2024 and FY2025 respectively. Net losses over the same years were $8.05 million, $1.31 million and $0.87 million, and cash and investments were $2.24 million, $2.07 million and $1.38 million. For the twelve months to December 2025, revenue was $8.46 million, the net loss was $0.81 million and cash was $1.04 million.

On those figures, the loss has narrowed materially since FY2023, while revenue has been broadly flat for two years and cash has declined. The company has not, on the figures reviewed, reported a profit. A narrowing loss is not the same as self-funding operations, and the Appendix 4C for the June 2026 quarter is the document to read for current cash and operating cash flow.

Risks and milestones

Software sold to medical practices competes with larger, better-funded vendors, and customer switching can be slow and costly in both directions, which makes growth hard to accelerate. Smaller listed technology companies can also face funding needs that lead to share issues and dilution. No Capital raising was identified in the announcements reviewed, and none should be assumed.

The interim report is expected around 24 February 2027, though no date has been confirmed. The last Annual General Meeting was held on 25 November 2025; no 2026 date was confirmed.